Samer Al-Dury

1.0k total citations
15 papers, 279 citations indexed

About

Samer Al-Dury is a scholar working on Hepatology, Infectious Diseases and Surgery. According to data from OpenAlex, Samer Al-Dury has authored 15 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 5 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Samer Al-Dury's work include SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease and Transplantation (4 papers). Samer Al-Dury is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Disease and Transplantation (4 papers). Samer Al-Dury collaborates with scholars based in Sweden, Austria and Denmark. Samer Al-Dury's co-authors include Hanns–Ulrich Marschall, Marcus Ståhlman, Annika Wahlström, Staffan Wåhlin, Ronald P.J. Oude Elferink, Fredrik Bäckhed, Michael Trauner, Katrin Panzitt, Anders Thorell and Martin Wagner and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Samer Al-Dury

13 papers receiving 272 citations

Peers

Countries citing papers authored by Samer Al-Dury

Since Specialization

Citations

This map shows the geographic impact of Samer Al-Dury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Al-Dury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Al-Dury more than expected).

Fields of papers citing papers by Samer Al-Dury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Al-Dury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Al-Dury. The network helps show where Samer Al-Dury may publish in the future.

Co-authorship network of co-authors of Samer Al-Dury

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Al-Dury. A scholar is included among the top collaborators of Samer Al-Dury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Al-Dury. Samer Al-Dury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities 2024 ·Vaccines ·Samer Al-Dury, Nelly Kanberg	3
2	Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation 2024 ·Scientific Reports ·Sigrun Einarsdottir, Samer Al-Dury, (unknown), (unknown), Hao Wang, (unknown), (unknown), (unknown), Johan Ringlander, Anna Martner, Kristoffer Hellstrand, J. Waldenström, Martin Lagging	1
3	Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients 2023 ·Frontiers in Immunology ·(unknown), (unknown), Samer Al-Dury, (unknown), (unknown), Johan Ringlander, Sigrun Einarsdottir, Magnus Lindh, Kristoffer Hellstrand, Martin Lagging, Anna Martner	1
4	Pyoderma gangrenosum as an initial presentation of Crohn’s colitis 2023 ·BMJ Case Reports ·(unknown), Samer Al-Dury	0
5	Catch-up antibody responses and hybrid immunity in mRNA vaccinated patients at risk of severe COVID-19 2023 ·Infectious Diseases ·Samer Al-Dury, J. Waldenström, Johan Ringlander, Sigrun Einarsdottir, (unknown), (unknown), (unknown), Anna Martner, Kristoffer Hellstrand, Martin Lagging	6
6	Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination 2022 ·JHEP Reports ·Samer Al-Dury, (unknown), J. Waldenström, (unknown), (unknown), (unknown), (unknown), (unknown), Sigrun Einarsdottir, Johan Ringlander, Gisela Ringström, Kristoffer Hellstrand, Anna Martner, Martin Lagging	13
7	Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity 2022 ·Blood Advances ·Sigrun Einarsdottir, Anna Martner, J. Waldenström, (unknown), Johan Ringlander, (unknown), (unknown), (unknown), Staffan Nilsson, (unknown), Malin S. Nilsson, (unknown), (unknown), Vanda Friman, Samer Al-Dury, Tomas Bergström, Per Ljungman, Mats Brune, Kristoffer Hellstrand, Martin Lagging	18
8	Appendicitis: a rare adverse event in colonoscopy 2021 ·BMJ Case Reports ·Samer Al-Dury, (unknown), Riadh Sadik, (unknown)	1
9	Propranolol-induced hallucinations mimicking encephalopathy in a patient with liver cirrhosis 2021 ·Scandinavian Journal of Gastroenterology ·Samer Al-Dury, Antonio Molinaro, (unknown)	5
10	Obeticholic acid may increase the risk of gallstone formation in susceptible patients 2019 ·Journal of Hepatology ·Samer Al-Dury, Annika Wahlström, Katrin Panzitt, Anders Thorell, Marcus Ståhlman, Michael Trauner, Peter Fickert, Fredrik Bäckhed, Lars Fändriks, Martin Wagner, Hanns–Ulrich Marschall	49
11	Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH 2018 ·Frontiers in Pharmacology ·Samer Al-Dury, Hanns–Ulrich Marschall	78
12	Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis 2018 ·Scientific Reports ·Samer Al-Dury, Annika Wahlström, Staffan Wåhlin, (unknown), Ronald P.J. Oude Elferink, Marcus Ståhlman, Hanns–Ulrich Marschall	69
13	Cyp3a11 is not essential for the formation of murine bile acids 2017 ·Biochemistry and Biophysics Reports ·Annika Wahlström, Samer Al-Dury, Marcus Ståhlman, Fredrik Bäckhed, Hanns–Ulrich Marschall	15
14	CYP3A11 is Dispensable for the Formation of Murine Bile Acids 2016 ·Journal of Hepatology ·Samer Al-Dury, Annika Wahlström, Marcus Ståhlman, Fredrik Bäckhed, (unknown)	0
15	Steatotic Rat Hepatocytes in Primary Culture Are More Susceptible to the Acute Toxic Effect of Acetaminophen 2012 ·Physiological Research ·Otto Kučera, Samer Al-Dury, Halka Lotková, Tomáš Roušar, (unknown), Zuzana Červinková	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact